Research programme: alpha-9alpha-10 nicotinic acetylcholine receptor modulators - Rapport Therapeutics
Alternative Names: Research programme: α9α10 nAChR - Rapport TherapeuticsLatest Information Update: 23 Sep 2024
At a glance
- Originator Rapport Therapeutics
- Class Sensory system agents; Small molecules
- Mechanism of Action NAChR alpha9 modulators; Nicotinic receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Hearing loss